)
Visual
test
Getinge
Getinge (GETI) investor relations material
Getinge Q4 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q4 2025 earnings summary27 Jan, 2026
Executive summary
Achieved record high organic sales in Q4 2025, with 1.2% organic net sales growth and 2.3% organic order intake growth, and full-year organic sales growth of 4.9%, driven by strong demand in ECLS therapy, Acute Care Therapies, Transplant Care, and ventilators.
Margins were heavily impacted by currency and tariffs, but full-year adjusted EBITA margin held steady at 14.0% despite over SEK 1 billion in headwinds.
Recurring revenue now constitutes about two-thirds of total sales, with a growing share from high-margin products and consumables.
Several important product launches and regulatory milestones, including Automatiq, Aquadis 44, new washer-disinfectors, and CE/PMA certifications.
Strong financial position maintained, with leverage well below internal thresholds and solid free cash flow.
Financial highlights
Q4 2025 net sales reached SEK 10,186M, with organic growth in all business areas except Life Science; full-year organic net sales up 4.9%.
Adjusted gross profit for Q4 was SEK 5,037M; adjusted EBITDA was SEK 1,809M (margin 17.8%); full-year adjusted EBITA at SEK 4,880M (margin 14.0%).
Free cash flow in Q4 was SEK 1.2B–1.7B; full-year free cash flow at SEK 2,652M.
Board proposed a dividend of SEK 4.75 per share.
Paragonix business exceeded $100M in sales, slightly dilutive to group and ACT margins.
Outlook and guidance
Organic net sales growth for 2026 is guided at 3%-5%, adjusted for the phase-out of Surgical Perfusion.
Margin expansion remains an ambition, with mitigation efforts focused on pricing, productivity, and cost control.
Tariffs and FX headwinds expected to persist in 2026, with tariffs projected at around SEK 500M.
Midterm guidance for adjusted EBITDA margin of 16%-19% by 2028 is reiterated.
Quality costs are expected to decline from the second half of 2026, supporting margin expansion.
Cardiosave: US market strategy post-FDA letter?
Acquisitions' impact on 2030 climate targets?
Surgical Perfusion phase-out: profitability impact?
CardioSave 510(k) confidence for Q2 2026
Life Science project delays and market recovery
Life Science divestment interest and capital use
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Latest summaries
- TimeTickerHeadlineOpen
- 6 FebHTOO
Resale registration for 71,429 shares via warrant, with proceeds only on exercise; financial risks persist. - 6 FebVSAT
Q3 revenue up 3% to $1.16B, net income $25M, strong cash flow, Ligado boost, satellite focus. - 6 FebWEC
Targets 7–8% EPS growth, $37.5B capex, and coal exit by 2032 amid surging data center demand. - 6 FebBR
Q2 FY26 recurring revenue grew 8% and adjusted EPS guidance was raised to 9-12%. - 6 FebFFWM
Merger vote includes new non-voting stock class with limited conversion and no voting rights. - 6 FebKKR
Charter amendments seek to modernize governance and establish one share, one vote by 2026. - 6 FebARI
Proposed $9B real estate loan portfolio acquisition highlights disciplined, long-term strategy. - 6 FebSMCI
Q2 revenue jumped 123% to $12.7B, with FY26 guidance raised to at least $40B. - 6 FebRJF
Record revenues and assets, higher dividend, and acquisitions despite lower net income. - 6 FebFFIE
Raising capital for global EV and AI expansion, with regulatory and dilution risks highlighted.
Next Getinge earnings date
Q1 202621 Apr, 2026
Getinge
Next Getinge earnings date
Q1 202621 Apr, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Getinge is a global medical technology company that offers products and solutions for operating rooms, intensive-care units, and sterilization departments. These are used for a wide range of surgeries, for patient treatment in critical conditions, and for sterilizing tools to be used in surgical procedures. Getinge offers one of the broadest portfolios in the industry, designed to meet the demands of complex and highly specialized healthcare environments. Getinge was founded in 1904 and is headquartered in Gothenburg, Sweden.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage